메뉴 건너뛰기




Volumn 111, Issue 2, 2012, Pages 73-74

MMP-7 as a Potential Marker of Cardiovascular Complications in Patients with Chronic Kidney Disease (CKD)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAS LIGAND; GELATINASE A; GELATINASE B; MATRILYSIN;

EID: 84864007090     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00898.x     Document Type: Letter
Times cited : (8)

References (5)
  • 1
    • 84859841473 scopus 로고    scopus 로고
    • Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target
    • Marson BP, Poli de Figueiredo CE, Tanus-Santos JE. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic Clin Pharmacol Toxicol 2012;110:409-15.
    • (2012) Basic Clin Pharmacol Toxicol , vol.110 , pp. 409-415
    • Marson, B.P.1    Poli de Figueiredo, C.E.2    Tanus-Santos, J.E.3
  • 2
    • 31344438587 scopus 로고    scopus 로고
    • Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
    • Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006;69:636-45.
    • (2006) Cardiovasc Res , vol.69 , pp. 636-645
    • Ye, S.1
  • 3
    • 84856496775 scopus 로고    scopus 로고
    • Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
    • Marson BP, Lacchini R, Belo V, Dickel S, da Costa BP, Poli de Figueiredo CE et al.Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. Am J Nephrol 2012;35:209-15.
    • (2012) Am J Nephrol , vol.35 , pp. 209-215
    • Marson, B.P.1    Lacchini, R.2    Belo, V.3    Dickel, S.4    da Costa, B.P.5    Poli de Figueiredo, C.E.6
  • 4
    • 80051544834 scopus 로고    scopus 로고
    • Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
    • Musiał K, Zwolińska D. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis. Apoptosis 2011;16:653-9.
    • (2011) Apoptosis , vol.16 , pp. 653-659
    • Musiał, K.1    Zwolińska, D.2
  • 5
    • 0036910998 scopus 로고    scopus 로고
    • Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand
    • Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002;408:155-61.
    • (2002) Arch Biochem Biophys , vol.408 , pp. 155-161
    • Vargo-Gogola, T.1    Crawford, H.C.2    Fingleton, B.3    Matrisian, L.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.